Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
J C Edberg, … , M Whitlow, R P Kimberly
J C Edberg, … , M Whitlow, R P Kimberly
Published January 1, 1991
Citation Information: J Clin Invest. 1991;87(1):58-67. https://doi.org/10.1172/JCI115001.
View: Text | PDF
Research Article

Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.

  • Text
  • PDF
Abstract

The isoform of Fc gamma RIII (CD16) expressed on PMN has a GPI membrane anchor, and in paroxysmal nocturnal hemoglobinuria (PNH) there is a deficiency in Fc gamma RIII expression on PMN. Contrary to expectation, however, CD16 expression is preserved (albeit at reduced levels) in all affected PNH PMN that completely lack the GPI-anchored proteins DAF (CD55) and CD59. Fc gamma RIII negative PMN are not observed in any of the six PNH patients examined in this study. Analysis of the molecular weight of both glycosylated and deglycosylated Fc gamma RIII from PMN with reduced Fc gamma RIII expression indicates no variations in size relative to normal donor Fc gamma RIIIPMN. Indeed, the Fc gamma RIII expressed at intermediate levels is phosphatidylinositol-specific phospholipase C (PI-PLC)-sensitive. Thus, there is no evidence suggestive of expression of a transmembrane isoform and all data indicate that Fc gamma RIIIPMN on affected cells in PNH is a GPI-linked isoform. With Fc gamma RIIIPMN expression preserved at reduced levels on affected cells in PNH, PMN from PNH patients retain the capacity to internalize the Fc gamma RIIIPMN-specific probe E-ConA (at reduced levels) as well as IgG-opsonized erythrocytes. Reduced expression of GPI-anchored molecules on PNH PMN is not restricted to Fc gamma RIIIPMN since intermediate levels of CD59 were observed in the PNH PMN that were decay-accelerating factor (DAF)-negative and Fc gamma RIIIPMN intermediate. In addition, discordant expression of GPI-linked molecules in individual cells is not restricted to PMN since DAF+/CD14- monocytes were observed in one PNH patient. These data suggest that, when analyzed on an individual cell level, the GPI anchor defect in PNH is not absolute and must involve either a hierarchy of access of different protein molecules to available GPI anchors, distinct anchor biochemistries for the different proteins, or differential regulation of protein-anchor assembly.

Authors

J C Edberg, J E Salmon, M Whitlow, R P Kimberly

×

Total citations by year

Year: 2019 2013 2008 2007 2006 2002 1998 1997 1996 1995 1994 1993 1992 1991 Total
Citations: 1 1 2 1 1 1 2 2 1 2 2 2 6 1 25
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (25)

Title and authors Publication Year
Human neutrophils express low levels of FcγRIIIA, which plays a role in PMN activation
J Golay, R Valgardsdottir, G Musaraj, D Giupponi, O Spinelli, M Introna
Blood 2019
Human intravenous immunoglobulin (hIVIG) inhibits anti-CD32 antibody binding to canine DH82 cells and canine monocytes in vitro
TA Sibley, MM Miller, JE Fogle
Veterinary Immunology and Immunopathology 2013
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND GLYCOSYL PHOSPHATIDYLINOSITOL ANCHORED PROTEINS THAT REGULATE COMPLEMENT
CJ Parker
Clinical & Experimental Immunology 2008
Detailed immunophenotypic characterization of different major and minor subsets of peripheral blood cells in patients with paroxysmal nocturnal hemoglobinuria
PM Hernndez-Campo, J Almeida, MJ Acevedo, ML Snchez, I Alberca, B Vidriales, E Martnez, JR Romero, A Orfao
Transfusion 2008
NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils
S von Vietinghoff, G Tunnemann, C Eulenberg, M Wellner, MC Cardoso, FC Luft, R Kettritz
Blood 2007
Normal patterns of expression of glycosylphosphatidylinositol-anchored proteins on different subsets of peripheral blood cells: A frame of reference for the diagnosis of paroxysmal nocturnal hemoglobinuria
PM Hernández-Campo, J Almeida, ML Sánchez, M Malvezzi, A Orfao
Cytometry Part B: Clinical Cytometry 2006
Detection of CD16 low neutrophil subpopulations: Letter to the Editor
N Riera, K Canalejo, M Aixalá, M Rosso, E Gaddi, MM de E. de Bracco, N Galassi
Cytometry. Part B, Clinical cytometry 2002
Expression of Functional CD32 Molecules on Human NK Cells Is Determined by an Allelic Polymorphism of the FcγRIIC Gene
D Metes, LK Ernst, WH Chambers, A Sulica, RB Herberman, PA Morel
Blood 1998
Carboxy-Terminal Processing of the Urokinase Receptor: Implications for Substrate Recognition and Glycosylphosphatidylinositol Anchor Addition
J Aceto, T Kieber-Emmons, DB Cines
Biochemistry 1998
Paroxysmal Nocturnal Hemoglobinuria as a Molecular Disease
WF Rosse
Medicine 1997
Paroxysmal Nocturnal Hemoglobinuria as a Molecular Disease:
WF Rosse
Medicine 1997
Role of allelic polymorphisms of Fcγ receptor IIa in systemic lupus erythematosus
JE Salmon
Clinical Immunology Newsletter 1996
Receptors for immunoglobulin g molecular diversity and implications for disease
RP Kimberly, JE Salmon, JC Edberg
Arthritis & Rheumatism 1995
Flow cytometric analysis of homologous restriction factor 20KD (HRF20) expression on progeny cells during differentiation from haemopoietic progenitors in paroxysmal nocturnal haemoglobinuria
T Nishimura, A Kanamaro, E Kakishita, K Nagai
British Journal of Haematology 1995
Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol anchor
ET Yeh, WF Rosse
Journal of Clinical Investigation 1994
Fc receptor-mediated signal transduction
, Z Shen, P Boros, JC Unkeless
Journal of Clinical Immunology 1994
Membrane proteins in paroxysmal nocturnal haemoglobinuria
B Rotoli, M Bessler, F Alfinito, L Vecchio
Blood Reviews 1993
Induction of FcγR-III (CD16) expression on neutrophils affected by paroxysmal nocturnal haemoglobinuria by administration of granulocyte colony-stimulating factor
H Ninomiya, Y Muraki, K Shibuya, T Nagasawa, T Abe
British Journal of Haematology 1993
Differential expression of glycosylphosphatidylinositol-anchored proteins in a murine T cell hybridoma mutant producing limiting amounts of the glycolipid core. Implications for paroxysmal nocturnal hemoglobinuria
LJ Thomas, M Urakaze, R DeGasperi, T Kamitani, E Sugiyama, HM Chang, CD Warren, ET Yeh
Journal of Clinical Investigation 1992
On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2
PW Parren, PA Warmerdam, LC Boeije, J Arts, NA Westerdaal, A Vlug, PJ Capel, LA Aarden, JG van de Winkel
Journal of Clinical Investigation 1992
Functional capacity of Fcγ receptor III (CD16) on human neutrophils
JC Edberg, JE Salmon, RP Kimberly
Immunologic Research 1992
Receptor specific probes for the study of Fcγ receptor specific function
JC Edberg, RP Kimberly
Journal of Immunological Methods 1992
The glycosylphosphatidylinositol-linked Fcγ receptor III represents the dominant receptor structure for immune complex activation of neutrophils
M Hundt, RE Schmidt
European Journal of Immunology 1992
Membrane Defenses Against Attack by Complement and Perforins
CJ Parker
1992
Paroxysmal nocturnal hemoglobinuria and glycosyl phosphatidylinositol anchored proteins that regulate complement
CJ Parker
Clinical & Experimental Immunology 1991

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts